NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
47 hedge funds and large institutions have $9.3M invested in NeuBase Therapeutics, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
75% less call options, than puts
Call options by funds: $236K | Put options by funds: $931K
Holders
47
Holding in Top 10
–
Calls
$236K
Puts
$931K
Top Buyers
| 1 | +$81.1K | |
| 2 | +$34K | |
| 3 | +$15.8K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$14.7K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.9K |
Top Sellers
| 1 | -$155K | |
| 2 | -$144K | |
| 3 | -$67.3K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$56.5K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$45K |